Blood Conservation

Journal of Arthroplasty

Volumn 29, Issue 2 SUPPL., 2014, Pages 65-70

  Rasouli, Mohammad R ^a   Gomes, Luiz Sérgio Marcelino ^a   Parsley, Brian ^a   Barsoum, Wael ^a   Bezwada, Hari ^a   Cashman, James ^a   Garcia, Julio ^a   Hamilton, William ^a   Hume, Eric ^a   Kim, Tae Kyun ^a   Malhotra, Rajesh ^a   Memtsoudis, Stavros G ^a   Ong, Alvin ^a   Orozco, Fabio ^a   Padgett, Douglas E ^a   Reina, Ricardo J ^a   Teloken, Marco ^a   Thienpont, Emmanuel ^a   Waters, Jonathan H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; TRANEXAMIC ACID;

ANESTHESIA; ARTHROPLASTY; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CONSERVATION; BLOOD SALVAGE; BLOOD TRANSFUSION; GENERAL ANESTHESIA; HEMODILUTION; HIP SURGERY; HUMAN; INDUCED HYPOTENSION; INFECTION RISK; OPERATIVE BLOOD LOSS; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE HEMORRHAGE; SUCTION PUMP; SURGICAL INFECTION; THROMBOCYTE RICH PLASMA; TOTAL HIP PROSTHESIS;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HEMOSTASIS, SURGICAL; HUMANS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 84892855759     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.09.032     Document Type: Article

References (95)

1. Healthcare Infection Control Practice Advisory Committee. CDC and HICPAC Draft Guideline for Prevention of Surgical Site Infection, Arthroplasty Section; Pending.
2. Innerhofer P., Klingler A., Klimmer C., et al. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 2005, 45(1):103.
3. Frietsch T., Karger R., Scholer M., et al. Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay. Transfusion 2008, 48(10):2133.
4. Carson J.L., Terrin M.L., Noveck H., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011, 365(26):2453.
5. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340(6):409.
6. Basora M., Pereira A., Soriano A., et al. Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty. Vox Sang 2010, 98(2):124.
7. Brandt C., Hansen S., Sohr D., et al. Finding a method for optimizing risk adjustment when comparing surgical-site infection rates. Infect Control Hosp Epidemiol 2004, 25(4):313.
8. Byrne A.M., Morris S., McCarthy T., et al. Outcome following deep wound contamination in cemented arthroplasty. Int Orthop 2007, 31(1):27.
9. Dale H., Hallan G., Espehaug B., et al. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 2009, 80(6):639.
10. Gastmeier P., Sohr D., Brandt C., et al. Reduction of orthopaedic wound infections in 21 hospitals. Arch Orthop Trauma Surg 2005, 125(8):526.
11. Jamsen E., Varonen M., Huhtala H., et al. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty 2010, 25(1):87.
12. Mraovic B., Suh D., Jacovides C., et al. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol 2011, 5(2):412.
13. Ong K.L., Kurtz S.M., Lau E., et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009, 24(6 Suppl):105.
14. Peersman G., Laskin R., Davis J., et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001, 392:15.
15. Procter LD, Davenport DL, Bernard AC, et al. General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg. 2010;210(1):60 e61.
16. Pulido L., Ghanem E., Joshi A., et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008, 466(7):1710.
17. Willis-Owen C.A., Konyves A., Martin D.K. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br 2010, 92(8):1128.
18. Park J.H., Rasouli M.R., Mortazavi S.M.J., et al. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am 2013, 95(19):1777.
19. Faris P.M., Spence R.K., Larholt K.M., et al. The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics 1999, 22(1 Suppl):s135.
20. Perazzo P., Vigano M., De Girolamo L., et al. Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation. Blood Transfus 2013, 11(7):370.
21. Hamaji A., Hajjar L., Caiero M., et al. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection. Rev Bras Anestesiol 2013, 63(1):27.
22. Xie R., Wang L., Bao H. Crystalloid and colloid preload for maintaining cardiac output in elderly patients undergoing total hip replacement under spinal anesthesia. J Biomed Res 2013, 25(3):185.
23. Casutt M., Kristoffy A., Schuepfer G., et al. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth 2010, 105(3):273.
24. Guay J. The effect of neuraxial blocks on surgical blood loss and blood transfusion requirements: a meta-analysis. J Clin Anesth 2006, 18(2):124.
25. Hu S., Zhang Z.Y., Hua Y.Q., et al. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br 2009, 91(7):935.
26. Macfarlane A.J., Prasad G.A., Chan V.W., et al. Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth 2009, 103(3):335.
27. Macfarlane A.J., Prasad G.A., Chan V.W., et al. Does regional anesthesia improve outcome after total knee arthroplasty?. Clin Orthop Relat Res 2009, 467(9):2379.
28. Mauermann W.J., Shilling A.M., Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 2006, 103(4):1018.
29. Stundner O., Chiu Y.L., Sun X., et al. Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty. Reg Anesth Pain Med 2012, 37(6):638.
30. Memtsoudis S.G., Sun X., Chiu Y.L., et al. Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology 2013, 118(5):1046.
31. Paul J.E., Ling E., Lalonde C., et al. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth 2007, 54(10):799.
32. Wedel D.J., Horlocker T.T. Regional anesthesia in the febrile or infected patient. Reg Anesth Pain Med 2006, 31(4):324.
33. Gritsenko K., Marcello D., Liguori G.A., et al. Meningitis or epidural abscesses after neuraxial block for removal of infected hip or knee prostheses. Br J Anaesth 2012, 108(3):485.
34. Chang C.C., Lin H.C., Lin H.W. Anesthetic management and surgical site infections in total hip or knee replacement: a population-based study. Anesthesiology 2010, 113(2):279.
35. Waters J.H., Tuohy M.J., Hobson D.F., et al. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology 2003, 99(3):652.
36. Barsoum W.K., Klika A.K., Murray T.G., et al. Prospective randomized evaluation of the need for blood transfusion during primary total hip arthroplasty with use of a bipolar sealer. J Bone Joint Surg Am 2011, 93(6):513.
37. Zeh A., Messer J., Davis J., et al. The Aquamantys system-an alternative to reduce blood loss in primary total hip arthroplasty?. J Arthroplasty 2010, 25(7):1072.
38. Clement R.C., Kamath A.F., Derman P.B., et al. Bipolar sealing in revision total hip arthroplasty for infection: efficacy and cost analysis. J Arthroplasty 2012, 27(7):1376.
39. Marulanda G.A., Ulrich S.D., Seyler T.M., et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008, 5(2):125.
40. Marulanda G.A., Krebs V.E., Bierbaum B.E., et al. Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am J Orthop (Belle Mead NJ) 2009, 38(12):E179.
41. Parker M.J., Livingstone V., Clifton R., et al. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev 2007, 3. CD001825.
42. Parker M.J., Roberts C.P., Hay D. Closed suction drainage for hip and knee arthroplasty. A meta-analysis. J Bone Joint Surg Am 2004, 86-A(6):1146.
43. Zamora-Navas P., Collado-Torres F., de la Torre-Solis F. Closed suction drainage after knee arthroplasty. A prospective study of the effectiveness of the operation and of bacterial contamination. Acta Orthop Belg 1999, 65(1):44.
44. Alshryda S., Sarda P., Sukeik M., et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011, 93(12):1577.
45. Kagoma Y.K., Crowther M.A., Douketis J., et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123(5):687.
46. Roberts I., Perel P., Prieto-Merino D., et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ 2012, 345:e5839.
47. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096 e1091.
48. Shakur H., Roberts I., Bautista R., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376(9734):23.
49. Sukeik M., Alshryda S., Haddad F.S., et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011, 93(1):39.
50. Zhang H., Chen J., Chen F., et al. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012, 20(9):1742.
51. Tan J., Chen H., Liu Q., et al. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 2013, 95(19):1777.
52. Zhou X.D., Tao L.J., Li J., et al. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 2013, 133(7):1017.
53. Zufferey P., Merquiol F., Laporte S., et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology 2006, 105(5):1034.
54. Zohar E., Ellis M., Ifrach N., et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004, 99(6):1679. table of contents.
55. Wong J., Abrishami A., El Beheiry H., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010, 92(15):2503.
56. Zohar E., Fredman B., Ellis M., et al. A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement. Anesth Analg 1999, 89(6):1382.
57. Ellis M.H., Fredman B., Zohar E., et al. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth 2001, 13(7):509.
58. Jansen A.J., Andreica S., Claeys M., et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999, 83(4):596.
59. Alvarez J.C., Santiveri F.X., Ramos I., et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008, 48(3):519.
60. Benoni G., Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996, 78(3):434.
61. Camarasa M.A., Olle G., Serra-Prat M., et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 2006, 96(5):576.
62. Engel J.M., Hohaus T., Ruwoldt R., et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 2001, 92(3):775.
63. Hiippala S., Strid L., Wennerstrand M., et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995, 74(5):534.
64. Hiippala S.T., Strid L.J., Wennerstrand M.I., et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997, 84(4):839.
65. Molloy D.O., Archbold H.A., Ogonda L., et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 2007, 89(3):306.
66. Benoni G., Fredin H., Knebel R., et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001, 72(5):442.
67. Benoni G., Lethagen S., Nilsson P., et al. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 2000, 71(3):250.
68. Claeys M.A., Vermeersch N., Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007, 107(4):397.
69. Ekback G., Axelsson K., Ryttberg L., et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000, 91(5):1124.
70. Garneti N., Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty 2004, 19(4):488.
71. Husted H., Blond L., Sonne-Holm S., et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 2003, 74(6):665.
72. Ido K., Neo M., Asada Y., et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 2000, 120(9):518.
73. Johansson T., Pettersson L.G., Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 2005, 76(3):314.
74. Lemay E., Guay J., Cote C., et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004, 51(1):31.
75. Niskanen R.O., Korkala O.L. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop 2005, 76(6):829.
76. Yamasaki S., Masuhara K., Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop 2004, 28(2):69.
77. Lin P.C., Hsu C.H., Huang C.C., et al. The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?. J Bone Joint Surg Br 2012, 94(7):932.
78. Aguilera X., Videla S., Almenara M., et al. Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop Belg 2012, 78(1):68.
79. Oremus K., Sostaric S., Trkulja V., et al. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion 2013, Apr 25 http://dx.doi.org/10.1111/trf.12224.
80. Diiorio T.M., Burkholder J.D., Good R.P., et al. Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA. Clin Orthop Relat Res 2012, 470(1):138.
81. Gardner M.J., Demetrakopoulos D., Klepchick P.R., et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007, 31(3):309.
82. Berghoff W.J., Pietrzak W.S., Rhodes R.D. Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics 2006, 29(7):590.
83. McConnell J.S., Shewale S., Munro N.A., et al. Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. Acta Orthop 2011, 82(6):660.
84. Mawatari M., Higo T., Tsutsumi Y., et al. Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg (Hong Kong) 2006, 14(2):117.
85. Levy O., Martinowitz U., Oran A., et al. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999, 81(11):1580.
86. Wang G.J., Goldthwaite C.A., Burks S., et al. Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 2003, 13(5):399.
87. Wang G.J., Hungerford D.S., Savory C.G., et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001, 83-A(10):1503.
88. Carless P.A., Henry D.A., Moxey A.J., et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010, 4. CD001888.
89. Waters J.H. Indications and contraindications of cell salvage. Transfusion 2004, 44(12 Suppl):40S.
90. Spahn D.R. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010, 113(2):482.
91. Feagan B.G., Wong C.J., Kirkley A., et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000, 133(11):845.
92. Delasotta L.A., Rangavajjula A., Frank M.L., et al. The Use of Preoperative Epoetin-alpha in Revision Hip Arthroplasty. Open Orthop J 2012, 6:179.
93. Delasotta L.A., Rangavajjula A.V., Frank M.L., et al. The Use of Epoetin-alpha in Revision Knee Arthroplasty. Adv Orthop 2012, 2012:595027.
94. Robinson A.H., Drew S., Anderson J., et al. Suction tip contamination in the ultraclean-air operating theatre. Ann R Coll Surg Engl 1993, 75(4):254.
95. Strange-Vognsen H.H., Klareskov B. Bacteriologic contamination of suction tips during hip arthroplasty. Acta Orthop Scand 1988, 59(4):410.